
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0012 | 0.166712975827 | 0.7198 | 0.765 | 0.6801 | 65985 | 0.72465077 | CS |
4 | 0.005 | 0.698324022346 | 0.716 | 0.765 | 0.6001 | 449197 | 0.68106524 | CS |
12 | 0.046 | 6.81481481481 | 0.675 | 1.05 | 0.6001 | 313471 | 0.71847797 | CS |
26 | -1.559 | -68.3771929825 | 2.28 | 2.31 | 0.6 | 417925 | 1.10095507 | CS |
52 | -3.719 | -83.7612612613 | 4.44 | 4.89 | 0.6 | 545802 | 1.92183183 | CS |
156 | -376.004 | -99.8086137103 | 376.725 | 459 | 0.6 | 1795996 | 53.62557567 | CS |
260 | -6749.279 | -99.9893185185 | 6750 | 8182.5 | 0.6 | 1542385 | 323.44731337 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관